Skip to main content
. 2018 Nov 26;27(4):237–242. doi: 10.1136/ejhpharm-2018-001666

Table 2.

Demographic and baseline characteristics of patients in the pre- and post-intervention groups

Characteristics Pre-intervention group (n=40) Post-intervention* group (n=43) Total (n=83)
Gender, n (%)
 Male 17 (42.5%) 20 (46.5%) 37 (44.6%)
Age (years) 72.8 (63.2, 81.3) 73.0 (54.7, 78.1) 73.9 (58.7, 81.8)
Weight (kg) 71.0 (55.2, 78.2) 75.1 (68.0, 85.2) 72.0 (60.4, 83.7)
Allergy, n (%)
 Beta-lactam antibiotics 1 (2.5%) 3 (6.9%) 4 (4.8%)
Lymphocyte count (x106/L)
 Pre 1.2 (0.8, 1.8) 1.9 (1.2, 2.3) 1.45 (1.0, 2.3)
 Post 1 (0.8, 1.3) 1.1 (0.9, 1.4) 1.1 (0.8, 1.3)
Neutrophil count (x109/L)
 Pre 5.3 (3.6, 6.4) 4.2 (3.3, 6.2) 4.7 (3.4, 6.3)
 Post 6.6 (4.2, 8.4) 6.7 (5.3, 8.6) 6.6 (5.2, 8.6)
Patients with renal impairment n (%)
 Mild
(<50 mg/mL)
5 (12.5%) 4 (9.3%) 9 (10.8%)
 Moderate
(<30 mg/mL)
2 (5.0%) 2 (4.6%) 4 (4,8%)
Haemoglobin level (g/dL)
 Pre 12.1 (10.7, 14.3) 13.4 (12.4, 14.8) 13.1 (11.3, 14.5)
 Post 10.7 (9.6, 12.1) 11.5 (10.2, 12.2) 11.2 (9.8, 12.1)
Orthopaedic procedure, n (%)
 Total knee replacement 15 (37.5%) 19 (44.2%) 34 (41.0%)
 Total hip replacement 15 (37.5%) 11 (25.6%) 26 (31.3%)
 Lower limb 8 (20.0%) 7 (16.3%) 15 (18.1)
 Spinal 2 (5.0%) 6 (13.9%) 8 (9.6%)

All values are expressed as median (IQR) unless stated otherwise.

*p>0.05; non-significant differences between groups in all variables collected.

†Pre, before surgery; post, after surgery.